JavaScript is disabled for your browser. Some features of this site may not work without it.
Attention submitters: Web accessibility policy to take effect October 15, 2019
For more information, please see our web accessibility policy and web accessibility help for submitters.
For more information, please see our web accessibility policy and web accessibility help for submitters.
2017 CVM News: Dr. Brian VanderVen's paper pinpoints a new target for tuberculosis drugs
Other Titles
New discovery holds potential as tuberculosis drug
Abstract
The news item from the Cornell Chronicle is about: Dr. Brian VanderVen, assistant professor of microbiology and immunology, and colleagues at Cornell’s College of Veterinary Medicine, have discovered a key metabolic mechanism in Mycobacterium tuberculosis (Mtb) bacteria, which presents as a novel drug target for potentially treating tuberculosis. The finding is published in the journal eLife.
Date Issued
2017-06-27Publisher
Cornell University, College of Veterinary Medicine
Subject
Cornell University. College of Veterinary Medicine -- Periodicals.; VanderVen, Brian; Roberts, Lauren Cahoon; Cornell Chronicle
Type
article